|
 |
Nome commerciale |
|
|
Trade names are indicative and excipients composition can be different depending on the country and manufacturers
|
|
Abbocurium |
Polonia |
|
Acurmil |
Italia |
|
Ancour |
Iran |
|
Anecur |
Iran |
|
Atacur |
Arabia Saudita |
|
Atacurin |
Iran |
|
Atrabesylate |
Egitto |
|
Atracur |
Ecuador |
|
Atracurio |
Argentina, Brasile, Spagna |
|
Atracurio besilato |
Chile, Italia, Perù, Venezuela |
|
Atracurium |
Arabia Saudita, Argentina, Austria, Egitto, Emirati Arabi Uniti, Germania, Gran Bretagna, Iran, Italia, Malaysia, Svezia |
|
Atracurium besilat |
Austria |
|
Atracurium besilate |
Arabia Saudita, Australia, Canada, Egitto, Emirati Arabi Uniti, Iran, nuova Zelanda, Stati Uniti d’America |
|
Atralex |
Malaysia |
|
Atrasyl |
Turchia |
|
Besilato Atracurio |
Chile, Portogallo, Spagna |
|
Besitrac |
Brasile |
|
Faulcurium |
Egitto, Portogallo |
|
Gelolagar |
Argentina |
|
Laurak |
Spagna |
|
Neucurium |
Turchia |
|
Notrixum |
Turchia |
|
Relactrac |
Colombia |
|
Relatrac |
Messico |
|
Tracrium |
Arabia Saudita, Argentina, Australia, Austria, Belgio, Chile, Colombia, Ecuador, Egitto, Emirati Arabi Uniti, Francia, Germania, Gran Bretagna, Grecia, Iran, Italia, Lussemburgo, Malaysia, Marocco, Messico, nuova Zelanda, Paesi Bassi, Polonia, Portogallo, Romania, Spagna, Stati Uniti d’America, Svezia, Svizzera, Tunisia, Ungheria |
|
Tracumek |
Perù |
|
Tracurix |
Argentina |
|
Tracuron |
Argentina |
|
|
 |
 |
Bibliografia : Atracurium besylate |
|
|
tipo |
pubblicazione |
| 285 |
Rivista |
Elmore RL, Contois ME, Kelly J, Noe A, Poirier A.
Stability and compatibility of admixtures of intravenous ciprofloxacin and selected drugs.
Clin Ther 1996 ; 18: 246-255. |
| 300 |
Rivista |
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1287-1292. |
| 319 |
Rivista |
Hadzija BW, Lubarsky DA.
Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia.
Am J Health-Syst Pharm 1995 ; 52: 997-999. |
| 402 |
Rivista |
Savitsky ME.
Visual compatibility of neuromuscular blocking agents with various injectable drugs during simulated Y-site injection.
Am J Hosp Pharm 1990 ; 47: 820-821. |
| 657 |
Rivista |
Pramar YV, Loucas VA, Word D.
Chemical stability and adsorption of atracurium besylate injections in disposable plastic syringes.
J Clin Pharm Ther 1996 ; 21: 173-175. |
| 660 |
Rivista |
Michaels MR, Stauffer GL, Haas DP.
Propofol compatibility with other intravenous drug products - Two new methods of evaluating IV emulsion compatibility.
Ann Pharmacotherapy 1996 ; 30: 228-232. |
| 813 |
Rivista |
Akkermann SR, Zhang H, Mullins RE, Yaughn K.
Stability of milrinone lactate in the presence of 29 critical care drugs and 4 IV solutions.
Am J Health-Syst Pharm 1999 ; 56: 63-68. |
| 865 |
Rivista |
Bhatt-Mehta V, Hirata S.
Physical compatibility and chemical stability of atracurium besylate and midazolam hydrochloride during intravenous coinfusion.
Int J Pharm Compound 1998 ; 2: 79-81. |
| 939 |
Rivista |
Gilbar PJ, Groves CF.
Visual compatibility of total parenteral nutrition solution (Synthamin 17 Premix*) with selected drugs during simulated Y-site injection.
Aust J Hosp Pharm 1994 ; 24: 167-170. |
| 1093 |
Rivista |
Fisher DM, Canfell, Miller RD.
Stability of atracurium administered by infusion.
Anesthesiology 1984 ; 61: 347-348. |
| 1611 |
Rivista |
Chalmers JR, Bobek MB, Militello MA.
Visual compatibility of amiodarone hydrochloride injection with various intravenous drugs.
Am J Health-Syst Pharm 2001 ; 58: 504-506. |
| 1647 |
Rivista |
Ackland G.
Physical incompatibility between atracurium and intravenous diclofenac.
Anaesthesia 2001 ; 56: 294. |
| 1721 |
Rivista |
Trissel LA, Williams KY, Baker MB.
Compatibility screening of Hextend during simulated Y-site administration with other drugs.
Int J Pharm Compound 2001 ; 5: 69-72. |
| 1803 |
Rivista |
Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB.
Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2003 ; 60: 80-85. |
| 3373 |
Rivista |
Khan S, Stannard N, Greijn J.
Precipitation of thiopental with muscle relaxants: a potential hazard.
J R Soc Med Sh Rep 2011 ; 2: 58. |
| 3502 |
Laboratorio |
Propofol (Diprivan®) - Summary of Products Characteristics
Astra Zeneca 2012 |
| 3629 |
Laboratorio |
Atracurium (Atracurium solution for injection/infusion®) - Summary of Product Characteristics
Actavis UK 2014 |
| 3659 |
Laboratorio |
Propofol (Diprivan®) - Résumé des caractéristiques du produit
AstraZeneca 2016 |
| 3676 |
Laboratorio |
Atracurium bésilate (Atracurium Hospira®) - Résumé des caractéristiques du produit
Hospira 2014 |
| 4428 |
Rivista |
Rashed S.M, Sweatman T.W, Thoma L, Hovinga C.A, Phelps S.J.
Chemical Compatibility of Depacon® with Medications Frequently Administered by Intravenous Y-Site Delivery in Patients with Epilepsy or Head Trauma.
J Pediatr Pharmacol Ther 2004 ; 9, 2: 126-132. |
|
|
